World’s first peer-reviewed study on anticancer benefits of ivermectin, mebendazole and fenbendazole published in reputable journal
The international Journal of Orthomolecular Medicine published a study on Sept. 19, 2024, that for the first time ever shows in peer-reviewed format that…
